Health & Fit: Opioid Crisis Cost U.S. Economy $631 Billion in Four Years, Study Shows - The FDA requests the removal of a painkiller for risk of abuse, a first - PressFrom - US

Health & Fit Opioid Crisis Cost U.S. Economy $631 Billion in Four Years, Study Shows

23:40  18 october  2019
23:40  18 october  2019 Source:

Recreational marijuana legalization reduces opioid deaths by 20%: study

Recreational marijuana legalization reduces opioid deaths by 20%: study States that legalize recreational marijuana see a reduction of at least 20 percent in fatalities linked to opioid overdoses, according to a study published Wednesday. 

The Society of Actuaries released a report Tuesday examining the economic impact of non-medical opioid usage in the United States, and it concludes that from 2015 to 2018 an estimated $631 billion was spent dealing with the crisis, with more to come.

Used syringe and opioid pills© Darwin Brandis / Getty Images Used syringe and opioid pills

The report, authored by Stoddard Davenport, MPH; Alexandra Weaver, ASA, MAAA and Matt Caverly, examines the cost of opioid misuse on a variety of areas, including health care expenditures, law enforcement and criminal justice programs and early mortality.

Opioid-related deaths increased dramatically in the period the study surveyed. According to the Centers for Disease Control, 33,091 opioid overdose deaths were reported in 2015, a figure that jumped to 42,249 the following year.

Decision expected in landmark opioid trial against Big Pharma

Decision expected in landmark opioid trial against Big Pharma Ruling in Oklahoma case will determine whether Johnson & Johnson and subsidiary Janssen downplayed addiction risks while marketing opioid painkillers

Early mortality represents the largest economic force in the study. The authors estimate that $253 billion of potential productivity and earnings are removed from the U.S. economy as a result of premature death as a result of opioid usage.

The second largest cost area is $205 billion in health care, which includes providing emergency services for overdoses and care for infants born with opioid withdrawal and abstinence syndromes.

The government has been saddled with a third of the total cost, primarily paid through Medicare and Medicaid, according to the report.

The authors also warn that the $631 billion figure is most likely underestimated, as they did not include any financial estimates from things they could not reliably measure including lost workplace productivity and diminished quality of life.

Trump administration announcing nearly $2B in opioid grants

Trump administration announcing nearly $2B in opioid grants WASHINGTON (AP) — The Trump administration is awarding nearly $2 billion in grants to states and local governments to help fight the opioid crisis. 

The study uses available data to project an estimate for 2019. The midpoint cost estimate of that data is $188 billion, indicating that the economic impacts of the opioid crisis are likely to continue to increase.

Many state and local governments are turning to the courts to address the crisis and hold the companies who made these products responsible.

The first high-profile trial of that nature begins this week, as Ohio's Cuyahoga and Summit Counties are bringing drug company Teva Pharmaceutical;  distributors McKesson, Henry Schein, Cardinal Health and AmerisourceBergen; and retailer Walgreens to court. Several other defendants in that case, including Johnson & Johnson and Allergan, have already agreed to settlements with the counties.

One of the largest manufacturers of synthetic opioids, Purdue Pharmaceutical, announced in September amidst multiple lawsuits that they were filing for Chapter 11 bankruptcy. They estimate that after the proceedings the company's assets will bring $10 billion to settle lawsuits across 24 states.

Doctors Are Taking Away Opioid Prescriptions From A Growing Number of Patients, Report Shows .
A federal guideline on removing patients from their opioid prescriptions was recently tempered, but not before physicians and hospital networks began aggressively removing people from their medication or sending them away entirely. HHS suggested tapering patients at gradual doses of about 10 percent a week or possibly less, but some clinicians and hospitals may have interpreted the guideline as a "hard stop," said the study, which was published November 15 in The Journal of the American Medical Association.

—   Share news in the SOC. Networks

Topical videos:

usr: 2
This is interesting!